AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05104073 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Provided with educational materials, guidelines and instructions.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Change in the incidence of hand eczema
Description: Assessed by the self-reported cases of newly-developed hand eczema. Change between baseline and 6 months.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Change in the incidence of hand eczema
Description: Assessed by the self-reported cases of newly-developed hand eczema. Change between baseline and 6 months.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Change in severity of hand eczema
Description: Assessed by using the Hand Eczema Severity Index (HECSI). HECSI score: 0-360 points (0 best, 360 worst). Change between baseline and 6 months.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Change in severity of hand eczema
Description: Assessed by using the Hand Eczema Severity Index (HECSI). HECSI score: 0-360 points (0 best, 360 worst). Change between baseline and 6 months.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Change in the number of self-reported days with absence from work due to having hand eczema
Description: Self-reported total number of sick days due to having hand eczema. Change between baseline and 6 months.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Change in the number of self-reported days with absence from work due to having hand eczema
Description: Self-reported total number of sick days due to having hand eczema. Change between baseline and 6 months.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Change in the number of participants being forced to change their job due to having hand eczema
Description: Self-reported change of job due to having hand eczema. Change between baseline and 6 months.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Change in the number of participants being forced to change their job due to having hand eczema
Description: Self-reported change of job due to having hand eczema. Change between baseline and 6 months.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Change in The Quality Of Life in in relation to hand eczema
Description: Assessed by using Hand Eczema Questionnaire (QolHEQ). Change between baseline and 6 months.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Change in The Quality Of Life in in relation to hand eczema
Description: Assessed by using Hand Eczema Questionnaire (QolHEQ). Change between baseline and 6 months.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Change in the level of knowledge regarding skin care and protection.
Description: Self-reported level of knowledge regarding skin care and protection. Change between baseline and 6 months.
Study NCT05763914 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Change in the level of knowledge regarding skin care and protection.
Description: Self-reported level of knowledge regarding skin care and protection. Change between baseline and 6 months.
Study NCT04565548 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational program for hypertensive patients
Description: The theory-guided program consisted of one session of health education, self-developed leaflet, and weekly text messaging for 12 weeks.
Study NCT04565548 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: One standardized health education and a leaflet developed by the Health Bureau. As similar as the intervention group, weekly text messaging will be delivered, but the content is not related to the blood pressure control.
Study NCT05857722 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Jóvenes Capibara
Description: Jóvenes Capibara is a 10-session group intervention that was culturally adapted from the Youth Readiness Intervention, which was originally developed in Sierra Leone for conflict-affected youth. Jóvenes Capibara was adapted to the Colombian context using the ADAPT-ITT framework, which ensured that the intervention was relevant to the needs of Colombian and Venezuelan youth.
Study NCT05857722 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Jóvenes Capibara
Description: Jóvenes Capibara is a 10-session group intervention that was culturally adapted from the Youth Readiness Intervention, which was originally developed in Sierra Leone for conflict-affected youth. Jóvenes Capibara was adapted to the Colombian context using the ADAPT-ITT framework, which ensured that the intervention was relevant to the needs of Colombian and Venezuelan youth.
Study NCT05621447 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAS-303, [14C]TAS-303
Description: oral administration on day 1
Study NCT04880668 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aerosol Box (Splashguard)
Description: The aerosol box is a transparent, plastic cube covering the patient's head and shoulders, with circular access ports on the front of the box allowing for access to manage the airway. An additional four access holes (i.e. two on either side of the box) allow for airway assistants to access the patient airway.
Study NCT05824000 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Eye drops for itchy and water eyes
Description: Ocular drops for itchy and watery eyes
Study NCT04792476 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High Intensity Interval Training
Description: Experimental group will receive, in addition to the conventional treatment, a physical exercise intervention along 12 weeks, which will consist of complying with the general recommendations for physical activity: 75 minutes weekly of high intensity physical exercise. The therapeutic exercise intervention will be supervised by a physiotherapist and designed in a progressive, structured and personalized way.
Study NCT06541496 — intervention group
Intervention type: DEVICE
Intervention: Multispectral Optoacoustic Tomography (MSOT)
Description: Non-invasive transcutaneous MSOT imaging of muscle regions.
Study NCT05073419 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Routine monitoring of post AMI patient with clinic visits
Study NCT05073419 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ICM Implantation
Description: Implantation of ICM through small incision (2 mm) under the skin
Study NCT05078203 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 36 minutes of Exercise
Study NCT05078203 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Exercise
Description: 36 minutes of Exercise
Study NCT04126044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06439535 (CN)
Description: This is the test drug Pfizer biosimilar of bevacizumab-EU.
Study NCT04126044 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bevacizumab - EU
Description: This is the reference drug bevacizumab sourced from EU
Study NCT05636813 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training
Description: Patients are trained to use AT (2 sessions of 4 hours). Written langage skills, autonomy, the use are evaluated before and after training.
Study NCT03164447 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UB-421
Description: Monoclonal antibody by IV infusion
Study NCT03164447 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Optimized background therapy (OBT)
Description: The prescribed OBT must contain at least one agent to which the participant's virus is known to be fully sensitive.
Study NCT04654377 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalised education
Description: Patients will be explained about their disease and possible outcomes based on clinical, biochemical and imaging data.
Study NCT06376487 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flow rate evaluation
Description: Four different randomized flow rates will be used for evaluation: 2.0 liter.Kg-1.min-1, 1.5 liter.Kg-1.min-1, 1.0 liter.Kg-1.min-1, 0.5 liter.Kg-1.min-1. At the end of the randomized order evaluation the infant will remain in the flow of 0.5 liter.Kg-1.min-1 for 5 minutes and then return to the flow of 2.0 liter.Kg-1.min-1. The EIT parameters, ultrasound assessment, and clinical variables will be collected at the end of the 5-minute stay in each lane.
Study NCT04907292 — intervention group
Intervention type: OTHER
Intervention: Obstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool
Description: The ObsQoR-10 tool aims to quantitatively measure functional recovery at 24 hours postpartum. It includes 10 questions on a 0 to 10 scale, aimed at pain management, the adverse effects of narcotics and the perception of recovery by the patient.
Study NCT05814315 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HOPE Intervention
Description: Participants used the Health Checkins Platform for 12 weeks for emotional support and to obtain pain management tools
Study NCT06008119 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tunlametinib plus Vemurafenib
Description: 12mg BID Tunlametinib+720mg BID Vemurafenib
Study NCT06008119 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy ± Cetuximab
Description: According to investigators' suggestion
Study NCT04868019 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fenofibrate Capsules
Description: Solutions will be prepared in the required strengths and labeled accordingly. Group A will receive Solution A i.e. Fenofibrate suspension is prepared by dissolving 200 mg capsule in 10 ml distilled water and given as a single dose of 10mg/kg (0.5 ml/kg) and Group B will receive solution B i.e. 0.5ml/ kg normal saline as a placebo. Both groups will receive LED phototherapy under standard conditions. The serum bilirubin level will be noted at the time of admission and then at 12hr, 24hr, and 48 hours of treatment
Study NCT04868019 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fenofibrate Capsules
Description: Solutions will be prepared in the required strengths and labeled accordingly. Group A will receive Solution A i.e. Fenofibrate suspension is prepared by dissolving 200 mg capsule in 10 ml distilled water and given as a single dose of 10mg/kg (0.5 ml/kg) and Group B will receive solution B i.e. 0.5ml/ kg normal saline as a placebo. Both groups will receive LED phototherapy under standard conditions. The serum bilirubin level will be noted at the time of admission and then at 12hr, 24hr, and 48 hours of treatment
Study NCT05419713 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual Stimuli for Space Perception
Description: The visual environment (e.g., target locations and texture backgrounds) will be varied and human behavioral responses (judged distances) will be measured to reveal the space perception and cognitive processes underlying space perception and navigation.
Study NCT06273280 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SOC
Description: Physician-guided GDMT up-titration
Study NCT06273280 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Protocolized up-titration
Description: Renal-based protocolized GDMT up-titration
Study NCT05003024 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TOF SCAN
Description: For each included patient, 2 monitorings (TOF Scan and ITF device) will be placed, one on each hand.~Once 2 contractions of the adductor pollicis muscle will be observed on the TOF Scan side following train of four stimulation, 2 mg/kg sugammadex will be injected. Train of four ratio (delivered every minute) will be recorded.~This sequence (tetanus 100 Hz followed by tetanus 50 Hz) will be repeated 5 times For each tetanus stimulation, the ratio between the residual force and the maximum force generated by the adductor pollicis muscle will be recorded (this ratio illustrates the fade phenomenon). At the end of this period lasting 23 minutes after sugammadex administration, anesthetic drug delivery will be stopped and the patient wil be allowed to recover.
Study NCT05003024 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ITF
Description: For each included patient, 2 monitorings (TOF Scan and ITF device) will be placed, one on each hand.~On the ITF device side, 3 minutes after sugammadex administration, a tetanus 100 Hz stimulation will be done followed 2 minutes later by a tetanus 50 Hz stimulation.~This sequence (tetanus 100 Hz followed by tetanus 50 Hz) will be repeated 5 times For each tetanus stimulation, the ratio between the residual force and the maximum force generated by the adductor pollicis muscle will be recorded (this ratio illustrates the fade phenomenon). At the end of this period lasting 23 minutes after sugammadex administration, anesthetic drug delivery will be stopped and the patient wil be allowed to recover.
Study NCT06047574 — intervention group
Intervention type: OTHER
Intervention: This study does not involve any interventions
Description: This study does not involve any interventions
Study NCT05899803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Posture Analysis
Description: This analysis consists of 13 different body parts and evaluates the body in terms of current posture changes. Our study evaluated children from two angles: posterior (head, shoulders, back, hips, feet, and arches) and lateral (neck, chest, shoulders, upper back, trunk, abdomen, and waist). In the scoring system, correct posture was recorded as five points, a moderate amount of deformity posture as three points, and severe deformity posture as one point. The total score calculated at the end of the questionnaire was a maximum of 65 points and a minimum of 13 points. The results of the analysis were evaluated as follows: ≥ 45 points, very good, 40-44 points good, 30-39 points moderate, 20-29 points poor, and a total score of ≤ 19 points.
Study NCT05899803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Posture Analysis
Description: This analysis consists of 13 different body parts and evaluates the body in terms of current posture changes. Our study evaluated children from two angles: posterior (head, shoulders, back, hips, feet, and arches) and lateral (neck, chest, shoulders, upper back, trunk, abdomen, and waist). In the scoring system, correct posture was recorded as five points, a moderate amount of deformity posture as three points, and severe deformity posture as one point. The total score calculated at the end of the questionnaire was a maximum of 65 points and a minimum of 13 points. The results of the analysis were evaluated as follows: ≥ 45 points, very good, 40-44 points good, 30-39 points moderate, 20-29 points poor, and a total score of ≤ 19 points.
Study NCT05899803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Physical activity level
Description: This questionnaire, administered to children aged 4-14, evaluates the activities performed during a week. The questionnaire consisted of nine questions, each of which was evaluated on a 5 points. One point indicated a low physical activity level and five points indicated a high physical activity level. Dividing the total score of the selected items by the number of items gives a summary score for the PAQ-C questionnaire. In our study, we used the Turkish version of the questionnaire, which was found to be reliable and valid.
Study NCT05899803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity level
Description: This questionnaire, administered to children aged 4-14, evaluates the activities performed during a week. The questionnaire consisted of nine questions, each of which was evaluated on a 5 points. One point indicated a low physical activity level and five points indicated a high physical activity level. Dividing the total score of the selected items by the number of items gives a summary score for the PAQ-C questionnaire. In our study, we used the Turkish version of the questionnaire, which was found to be reliable and valid.
Study NCT05899803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Muscle strength
Description: Our study objectively measured muscle strength using the JTech Commander PowerTrack Muscle Dynamometer.~Right and left muscle tests: Hip flexors/hyperextensors/adductors/abductors/internal rotators/external retractors, knee flexors/extensors, and foot plantar flexors/dorsiflexors were evaluated. The measurement results were recorded in Newtons, the measurements were repeated three times, and the average of these three repetitions was recorded.
Study NCT05899803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Muscle strength
Description: Our study objectively measured muscle strength using the JTech Commander PowerTrack Muscle Dynamometer.~Right and left muscle tests: Hip flexors/hyperextensors/adductors/abductors/internal rotators/external retractors, knee flexors/extensors, and foot plantar flexors/dorsiflexors were evaluated. The measurement results were recorded in Newtons, the measurements were repeated three times, and the average of these three repetitions was recorded.
Study NCT05842642 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Cervical
Description: 6 weeks of treatment
Study NCT05842642 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cervical
Description: 6 weeks of treatment
Study NCT05842642 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oculomotor
Description: 6 weeks of treatment
Study NCT06507280 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Periodontal theraphy
Description: periodontal therapy
Study NCT05069636 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lymphatic OMM
Description: Patients receive lymphatic myofascial release and thoracic pump techniques.
Study NCT05069636 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Light Touch
Description: Patients receive a series of light touch techniques.
Study NCT06283862 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Session
Description: The initial session will last about 45 to 60 minutes. The subsequent 3 sessions are anticipated to take about 20-30 minutes.
Study NCT06283862 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Educational Session
Description: The initial session will last about 45 to 60 minutes. The subsequent 3 sessions are anticipated to take about 20-30 minutes.
Study NCT05034731 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Remote Fitting
Description: Processors will be programmed using remote fitting application.
Study NCT05034731 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: In-Office Fitting
Description: Processors will be programmed using standard Target CI application.
Study NCT02097446 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Guardix-FL
Study NCT02097446 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Interceed
Study NCT04760067 — intervention group
Intervention type: OTHER
Intervention: Sports Injury Anxiety Scale
Description: Sports Injury Anxiety Scale
Study NCT05310565 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: HVLA cervical chiropractic adjustments
Description: Chiropractic high velocity low amplitude adjustment
Study NCT05179746 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implants are decontaminated with electrolytic cleaning
Description: Implants are decontaminated with electrolytic cleaning
Study NCT05179746 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Implants are decontaminated without electrolytic cleaning
Description: Implants are decontaminated without electrolytic cleaning
Study NCT05653947 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Root canal instrumentation, 2.5% NaOCl irrigation
Description: Root canal instrumentation, 2.5% NaOCl irrigation
Study NCT05653947 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Root canal instrumentation, 2.5% NaOCl irrigation
Description: Root canal instrumentation, 2.5% NaOCl irrigation
Study NCT05860569 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: GC304
Description: Self-complementary adeno-associated virus serotype 5 (AAV5) carrying a codon-optimized LPL coding sequence(coLPL) driven by a liver-specific promoter (LP)
Study NCT05625724 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Experimental drug administrated orally
Study NCT05625724 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Treatment for the control group
Study NCT06518733 — intervention group
Intervention type: OTHER
Intervention: appliance type
Description: different types of appliances: labial fixed appliances only, fixed retainers, palatal appliances and miniscrews
Study NCT05060575 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education and Telephone Counceling
Description: Drug use and rational drug use training will be given to hypertension patients in the experimental group.~The patients in the experimental group twice in the 1st month (2nd and 4th weeks), once in the 2nd month (8th week) and once in the 3rd month (12th week) phone call counseling will be providedved an average of 10-15 minutes.
Study NCT05060575 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education and Telephone Counceling
Description: Drug use and rational drug use training will be given to hypertension patients in the experimental group.~The patients in the experimental group twice in the 1st month (2nd and 4th weeks), once in the 2nd month (8th week) and once in the 3rd month (12th week) phone call counseling will be providedved an average of 10-15 minutes.
Study NCT02653911 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Hwato Brand, Suzhou Medical Appliance Factory, China